FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies

This collection by leading scholars and government and private industry experts features essays on effective regulation in an era of globalization, consumer empowerment and comparative effectiveness, as well as questions of data transparency, conflicts of interest, industry responsibility and innovation policy.